* Shockwave Medical Inc SWAV.OQ SWAV.O is expected
to show a
rise in quarterly revenue when it reports results on November
7.
* The Santa Clara California-based company is expected to
report
a 90.3% increase in revenue to $123.966 million from $65.16
million a year ago, according to the mean estimate from 6
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Shockwave Medical
Inc is
for earnings of 67 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Shockwave
Medical
Inc is $260, below its last closing price of $274.39.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2022 0.44 0.44 0.68 Beat 54.5
Mar. 31 2022 0.18 0.18 0.39 Beat 111.6
Dec. 31 2021 0.11 0.09 0.34 Beat 300
Sep. 30 2021 -0.05 -0.06 0.05 Beat 187.5
Jun. -0.37 -0.40 -0.01 Beat 97.5
30 2021
Mar. 31 2021 -0.46 -0.45 -0.68 Missed -52.2
Dec. 31 2020 -0.42 -0.42 -0.46 Missed -8.7
Sep. 30 2020 -0.56 -0.55 -0.38 Beat 31.3
This summary was machine generated November 5 at 03:23 GMT. All
figures in US dollars unless otherwise stated